Displaying items by tag: department of medicine

AFib is expected to affect 40 million people worldwide and can be fatal if not treated. UAB experts provide tips on symptoms, risk factors and management of this condition.
By showing a critical role for sialylation in the biophysical properties of mucus and mucus transport, the study identifies a possible therapeutic target for the treatment of cystic fibrosis and other muco-obstructive diseases.
See the powerful documentary “The Last Ecstatic Days” at UAB's ALys Stephens Center and hear about the cultural and spiritual considerations of dying from UAB caregivers and Aditi Sethi, M.D., with The Center for Conscious Living & Dying, with guest artist Manjari Sharma.
Researchers at UAB shed light on the link between genetic variants and cardiovascular risk factors in determining heart health.
This past June, through a competitive review process, the NIH renewed their five-year grant to continue UAB’s Center for AIDS Research pivotal work.  
This study is providing researchers with an infrastructure they can build upon as they work to fully understand how exercise impacts the entire body.
The study will observe two sedation medications, ketamine and etomidate, that are most commonly used for sedations, ketamine and etomidate, to determine which is best during intubations.
Ninety-two percent of evaluable patients treated with INB-200 exceeded a median progression-free survival of seven months. Glioblastoma multiforme is the most aggressive type of cancer originating in the brain.
With more than 3,300 residents living in East Lake, Live HealthSmart Alabama hopes to encourage a healthier lifestyle by providing safe spaces for them to get outside.
Chronic obstructive pulmonary disease patients with type 2 inflammation saw rapid and sustained improvements after treatment with the monoclonal antibody dupilumab.
Page 1 of 37